Physician profile
Jacob Ossoff
NPI 1073958989
$5,429.91
in general payments reported to CMS, 2019-2025
16 companies · $614 in 2025
The $614 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,975 · 2020: $287 · 2021: $138 · 2022: $1,201 · 2023: $733 · 2024: $481 · 2025: $614.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,478 · Travel and Lodging: $351.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,478.08 |
| Travel and Lodging | $350.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $1,822.29 | 2019-2020 | |
| Stryker Corporation | $1,340.88 | 2019-2025 | Scopis Ent, Medline Industries, INC., Entellus Medical Focess Sinuscope |
| Medical Device Business Services, INC. | $751.88 | 2022 | |
| Aerin Medical INC. | $554.41 | 2022-2025 | |
| Optinose US, INC. | $238.58 | 2019-2025 | |
| Medtronic, INC. | $200.26 | 2022-2024 | Propel, Sinuva |
| Genzyme Corporation | $113.77 | 2019-2025 | |
| Glaxosmithkline, LLC. | $112.32 | 2023-2025 | Nucala |
| Inspire Medical Systems, INC. | $103.40 | 2023-2024 | Inspire |
| Acclarent, INC | $54.11 | 2022-2024 | Acclarent Aera |
| Phadia US INC. | $38.82 | 2023 | Immunocap |
| Merck Sharp & Dohme LLC | $28.27 | 2023 | |
| Integra Lifesciences Corporation | $24.75 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Getinge USA Sales, LLC | $18.91 | 2025 | Ultima Activator II Drive Mechanism |
| Smith+Nephew, INC. | $14.47 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Forte Bio-Pharma LLC | $12.79 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Ossoff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.